The strong robustness of our meta-analyses for other clinicopathological characteristics and prognostic value of HSP27 expression for 5-year OS of NSCLC was confirmed by further sensitivity analysis. This evidence concerns the gene HSPB1 and non-small cell lung carcinoma.